The National Institute of Allergy and Infectious Diseases is considering granting an exclusive patent license to Cambridge Enterprise Limited, part of the University of Cambridge, to develop and market certain inventions. These inventions involve conductive polymer coated electrodes used for single-cell electroporation in clinical settings. This license would help consolidate patent rights and speed up the commercial development of the invention, which is in line with promoting innovation according to U.S. law. Public comments or applications for this license must be submitted by May 2, 2025, and will be considered by the institute.
Simple Explanation
The National Institute of Allergy and Infectious Diseases wants to let Cambridge University use their special electrode invention so that it can help doctors treat people better, but they want people to share their thoughts about this plan by May 2, 2025.